Past Tuesday Talks: The Research Reproducibility Problem & its Impact on Drug Discovery
Tuesday, January 24th, 2023
Presented by Seema Kumar, CEO, Cure
“…for most study designs and settings, it is more likely for a research claim to be false than true.” – John Ioannidis, physician and researcher, Stanford, in PloS
It’s widely known that the results in at least half of all life published science studies cannot be reproduced when researchers try to verify results. What’s less known is what happens when potential therapeutics move from the lab to companies looking to develop new drugs and treatments. Christine Brideau is well-acquainted with this verification gap from her work at the fulcrum of turning basic research into products working at Deerfield and previously at WuXi and Merck. Join us on January 24 as she describes recent studies on reproducibility from the likes of Bayer and Amgen, and also shares her own experience and insights—and offers suggestions for how to narrow the verification gap.